Neuropharmacological Interventions in Neurodegenerative Disorders

This track is dedicated to exploring pharmacological strategies for treating neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Researchers are encouraged to submit abstracts on novel drug candidates, mechanisms of action, and clinical trial results. The track will cover both symptomatic treatments and disease-modifying therapies, with a focus on advancing our understanding of neurodegenerative processes. Attendees will learn about the latest therapeutic approaches that aim to slow or halt the progression of these debilitating diseases.

    Related Conference of Neuropharmacological Interventions in Neurodegenerative Disorders

    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    April 27-28, 2026

    11th World Kidney Congress

    London, UK
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Neuropharmacological Interventions in Neurodegenerative Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in